Bank of New York Mellon’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-7,031
Closed -$19K 4353
2019
Q1
$19K Sell
7,031
-214
-3% -$578 ﹤0.01% 4158
2018
Q4
$15K Hold
7,245
﹤0.01% 4173
2018
Q3
$33K Hold
7,245
﹤0.01% 4161
2018
Q2
$33K Sell
7,245
-2,843
-28% -$12.9K ﹤0.01% 4129
2018
Q1
$72K Buy
10,088
+1,933
+24% +$13.8K ﹤0.01% 4098
2017
Q4
$59K Buy
8,155
+910
+13% +$6.58K ﹤0.01% 4167
2017
Q3
$60K Sell
7,245
-589
-8% -$4.88K ﹤0.01% 4081
2017
Q2
$80K Buy
7,834
+59
+0.8% +$603 ﹤0.01% 4064
2017
Q1
$90K Buy
7,775
+530
+7% +$6.14K ﹤0.01% 4047
2016
Q4
$92K Sell
7,245
-538
-7% -$6.83K ﹤0.01% 4038
2016
Q3
$142K Sell
7,783
-1,250
-14% -$22.8K ﹤0.01% 3968
2016
Q2
$96K Sell
9,033
-20,345
-69% -$216K ﹤0.01% 4065
2016
Q1
$555K Sell
29,378
-604
-2% -$11.4K ﹤0.01% 3391
2015
Q4
$798K Buy
29,982
+150
+0.5% +$3.99K ﹤0.01% 3299
2015
Q3
$1.36M Sell
29,832
-6,153
-17% -$281K ﹤0.01% 2978
2015
Q2
$1.16M Buy
35,985
+2,242
+7% +$72.2K ﹤0.01% 3250
2015
Q1
$1.07M Sell
33,743
-3,380
-9% -$108K ﹤0.01% 3266
2014
Q4
$1.4M Sell
37,123
-1,242
-3% -$46.9K ﹤0.01% 3094
2014
Q3
$1.01M Buy
38,365
+5,281
+16% +$139K ﹤0.01% 3277
2014
Q2
$980K Buy
33,084
+2,590
+8% +$76.7K ﹤0.01% 3322
2014
Q1
$1.13M Sell
30,494
-1,741
-5% -$64.4K ﹤0.01% 3207
2013
Q4
$1.34M Sell
32,235
-32
-0.1% -$1.33K ﹤0.01% 3124
2013
Q3
$1.71M Buy
32,267
+550
+2% +$29.2K ﹤0.01% 2935
2013
Q2
$1.69M Buy
+31,717
New +$1.69M ﹤0.01% 2893